ENDEAVOUR SILVER CORP (EXK) Fundamental Analysis & Valuation

NYSE:EXK • CA29258Y1034

11.435 USD
-0.07 (-0.65%)
Last: Mar 6, 2026, 11:38 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This EXK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall EXK gets a fundamental rating of 3 out of 10. We evaluated EXK against 157 industry peers in the Metals & Mining industry. EXK may be in some trouble as it scores bad on both profitability and health. EXK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. EXK Profitability Analysis

1.1 Basic Checks

  • In the past year EXK has reported negative net income.
  • In the past year EXK had a positive cash flow from operations.
  • In multiple years EXK reported negative net income over the last 5 years.
  • EXK had a positive operating cash flow in each of the past 5 years.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

  • With a Return On Assets value of -9.64%, EXK is not doing good in the industry: 68.15% of the companies in the same industry are doing better.
  • With a Return On Equity value of -20.57%, EXK is not doing good in the industry: 70.70% of the companies in the same industry are doing better.
  • EXK has a Return On Invested Capital (2.97%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EXK is significantly below the industry average of 11.01%.
  • The 3 year average ROIC (2.02%) for EXK is below the current ROIC(2.97%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.64%
ROE -20.57%
ROIC 2.97%
ROA(3y)-4.24%
ROA(5y)-1.29%
ROE(3y)-8.49%
ROE(5y)-3.53%
ROIC(3y)2.02%
ROIC(5y)2.75%
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • With a decent Operating Margin value of 7.72%, EXK is doing good in the industry, outperforming 61.78% of the companies in the same industry.
  • EXK's Operating Margin has declined in the last couple of years.
  • EXK has a Gross Margin (17.71%) which is in line with its industry peers.
  • EXK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.72%
PM (TTM) N/A
GM 17.71%
OM growth 3Y-9.59%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.27%
GM growth 5Y-2.12%
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. EXK Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXK is destroying value.
  • EXK has more shares outstanding than it did 1 year ago.
  • EXK has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EXK is higher compared to a year ago.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • EXK has an Altman-Z score of 3.17. This indicates that EXK is financially healthy and has little risk of bankruptcy at the moment.
  • EXK has a Altman-Z score of 3.17. This is comparable to the rest of the industry: EXK outperforms 45.22% of its industry peers.
  • EXK has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
  • EXK has a worse Debt to Equity ratio (0.41) than 67.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 3.17
ROIC/WACC0.29
WACC10.14%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that EXK should not have too much problems paying its short term obligations.
  • EXK's Current ratio of 1.53 is on the low side compared to the rest of the industry. EXK is outperformed by 72.61% of its industry peers.
  • EXK has a Quick Ratio of 1.30. This is a normal value and indicates that EXK is financially healthy and should not expect problems in meeting its short term obligations.
  • EXK's Quick ratio of 1.30 is in line compared to the rest of the industry. EXK outperforms 42.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.3
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. EXK Growth Analysis

3.1 Past

  • EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.50%.
  • EXK shows a strong growth in Revenue. In the last year, the Revenue has grown by 114.81%.
  • EXK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.55% yearly.
EPS 1Y (TTM)-87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)114.81%
Revenue growth 3Y30.54%
Revenue growth 5Y27.55%
Sales Q2Q%309%

3.2 Future

  • EXK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.30% yearly.
  • Based on estimates for the next years, EXK will show a quite strong growth in Revenue. The Revenue will grow by 19.90% on average per year.
EPS Next Y335.67%
EPS Next 2Y183.31%
EPS Next 3Y86.87%
EPS Next 5Y63.3%
Revenue Next Year70.01%
Revenue Next 2Y37.76%
Revenue Next 3Y19.9%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

2

4. EXK Valuation Analysis

4.1 Price/Earnings Ratio

  • EXK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 32.35, the valuation of EXK can be described as expensive.
  • EXK's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.79, EXK is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 32.35
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

  • EXK's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.21
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • EXK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as EXK's earnings are expected to grow with 86.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y183.31%
EPS Next 3Y86.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EXK Dividend Analysis

5.1 Amount

  • No dividends for EXK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EXK Fundamentals: All Metrics, Ratios and Statistics

ENDEAVOUR SILVER CORP

NYSE:EXK (3/6/2026, 11:38:05 AM)

11.435

-0.07 (-0.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-27
Earnings (Next)05-11
Inst Owners55.15%
Inst Owner Change2.76%
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap3.38B
Revenue(TTM)467.50M
Net Income(TTM)-119.10M
Analysts80
Price Target13.51 (18.15%)
Short Float %5.81%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-94.59%
Min EPS beat(2)-117.47%
Max EPS beat(2)-71.71%
EPS beat(4)0
Avg EPS beat(4)-1508.19%
Min EPS beat(4)-5248.51%
Max EPS beat(4)-71.71%
EPS beat(8)1
Avg EPS beat(8)-1051.42%
EPS beat(12)2
Avg EPS beat(12)-717.41%
EPS beat(16)3
Avg EPS beat(16)-575.28%
Revenue beat(2)1
Avg Revenue beat(2)5.12%
Min Revenue beat(2)-6.69%
Max Revenue beat(2)16.94%
Revenue beat(4)3
Avg Revenue beat(4)2.6%
Min Revenue beat(4)-6.69%
Max Revenue beat(4)16.94%
Revenue beat(8)6
Avg Revenue beat(8)2%
Revenue beat(12)8
Avg Revenue beat(12)-0.31%
Revenue beat(16)10
Avg Revenue beat(16)-0.25%
PT rev (1m)19.31%
PT rev (3m)32.29%
EPS NQ rev (1m)-22.22%
EPS NQ rev (3m)-39.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)37.31%
Revenue NY rev (1m)4.9%
Revenue NY rev (3m)10.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.35
P/S 7.23
P/FCF N/A
P/OCF 50.17
P/B 5.84
P/tB 5.84
EV/EBITDA 31.21
EPS(TTM)-0.15
EYN/A
EPS(NY)0.35
Fwd EY3.09%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)0.23
OCFY1.99%
SpS1.58
BVpS1.96
TBVpS1.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.64%
ROE -20.57%
ROCE 3.76%
ROIC 2.97%
ROICexc 3.84%
ROICexgc 3.84%
OM 7.72%
PM (TTM) N/A
GM 17.71%
FCFM N/A
ROA(3y)-4.24%
ROA(5y)-1.29%
ROE(3y)-8.49%
ROE(5y)-3.53%
ROIC(3y)2.02%
ROIC(5y)2.75%
ROICexc(3y)2.47%
ROICexc(5y)3.78%
ROICexgc(3y)2.47%
ROICexgc(5y)3.78%
ROCE(3y)2.55%
ROCE(5y)3.48%
ROICexgc growth 3Y-17.38%
ROICexgc growth 5YN/A
ROICexc growth 3Y-17.38%
ROICexc growth 5YN/A
OM growth 3Y-9.59%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.27%
GM growth 5Y-2.12%
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA 2.14
Cap/Depr 229.27%
Cap/Sales 36.19%
Interest Coverage 2.3
Cash Conversion 61.33%
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.3
Altman-Z 3.17
F-Score3
WACC10.14%
ROIC/WACC0.29
Cap/Depr(3y)422.04%
Cap/Depr(5y)381.45%
Cap/Sales(3y)61.1%
Cap/Sales(5y)53.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y335.67%
EPS Next 2Y183.31%
EPS Next 3Y86.87%
EPS Next 5Y63.3%
Revenue 1Y (TTM)114.81%
Revenue growth 3Y30.54%
Revenue growth 5Y27.55%
Sales Q2Q%309%
Revenue Next Year70.01%
Revenue Next 2Y37.76%
Revenue Next 3Y19.9%
Revenue Next 5YN/A
EBIT growth 1Y324.28%
EBIT growth 3Y18.03%
EBIT growth 5YN/A
EBIT Next Year400.69%
EBIT Next 3Y87.9%
EBIT Next 5Y44.51%
FCF growth 1Y42.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y252.64%
OCF growth 3Y7.02%
OCF growth 5Y11.59%

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a valuation rating of 2 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Overvalued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 3 / 10.


Can you provide the financial health for EXK stock?

The financial health rating of ENDEAVOUR SILVER CORP (EXK) is 3 / 10.


What is the expected EPS growth for ENDEAVOUR SILVER CORP (EXK) stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to grow by 335.67% in the next year.